Karyopharm Therapeutics
KPTI
#9201
Rank
HK$0.64 B
Marketcap
HK$5.14
Share price
-3.17%
Change (1 day)
-27.64%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: HK$0.64 Billion

As of January 2025 Karyopharm Therapeutics has a market cap of HK$0.64 Billion. This makes Karyopharm Therapeutics the world's 9201th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$0.64 B-5.46%
2024HK$0.68 B-11.24%
2023HK$0.77 B-74.27%
2022HK$3.00 B-20.6%
2021HK$3.78 B-57.11%
2020HK$8.83 B-9.5%
2019HK$9.75 B118.66%
2018HK$4.46 B26.13%
2017HK$3.53 B17.71%
2016HK$3.00 B-18.38%
2015HK$3.68 B-61.2%
2014HK$9.49 B80.53%
2013HK$5.25 B

End of Day market cap according to different sources

On Jan 29th, 2025 the market cap of Karyopharm Therapeutics was reported to be:

HK$0.64 Billion
by Nasdaq info icon info icon
HK$0.64 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$1.936 T 298,224.15%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$933.03 B 143,611.31%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.727 T 266,011.44%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$73.33 B 11,194.79%๐Ÿ‡บ๐Ÿ‡ธ USA